Cargando…
Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology
Hepatocellular carcinoma (HCC) is one of the most common solid tumor malignancies in the world and represents roughly 90% of all primary malignancies of the liver. The most common risk factors for HCC include hepatitis B virus, hepatitis C virus, alcohol, and increasingly, fatty liver. Most HCC is d...
Autores principales: | Coffin, Philip, He, Aiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487618/ https://www.ncbi.nlm.nih.gov/pubmed/37686079 http://dx.doi.org/10.3390/ijms241713274 |
Ejemplares similares
-
Precision oncology and molecular therapies for hepatocellular carcinoma
por: Chen, Liming, et al.
Publicado: (2022) -
Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021) -
Past, Present, and Future of Molecular and Cellular Oncology
por: Galluzzi, Lorenzo, et al.
Publicado: (2011) -
Systemic treatment of hepatocellular carcinoma: Past, present and future
por: Cidon, Esther Una
Publicado: (2017) -
Liver Transplantation for Hepatocellular Carcinoma: Past, Present and Future
por: Saidi, Reza F., et al.
Publicado: (2013)